U.S. intelligence agencies are anticipating budget reductions of billions of dollars, said Director of National Intelligence James Clapper yesterday. He said he had just submitted a draft budget to OMB (presumably for FY 2013) that involved “double digit” cuts to the intelligence budget over ten years. See “U.S. Spies Facing Tens of Billions in Budget Cuts” by Sharon Weinberger, Wired Danger Room, October 17.
“In the last 10 years,… all we had to do essentially was preside over handing out more money and more people every year,” DNI Clapper told a joint hearing of the House and Senate Intelligence Committees last month.
But “now we’re in a ‘we’re-running-out-of-money-so-we-must-begin-to-think’ mode,” he said. “I think that is serving as the stimulus, if you will, to do some more creative thinking. I think this would do wonders in terms of saving money, efficiency, and promoting integration.”
“Everything we do in intelligence… is not of equal merit. Some things are more valuable than others, particularly as we look to the future. I think it’s very important to try to protect that valuable and most valuable resource we have, which is our people. We must continue some way of hiring every year, which we didn’t do in many cases during that seven-year hiatus period [in the 1990s]. We must try to sustain healthy R&D for the future. And I think we have to be rather cold-hearted and objective about the real contribution the various systems make. So that’s kind of the approach we’re going to take,” DNI Clapper told Congress last month.
“I don’t want anyone to be under the mistaken impression that we are going to sustain all the capabilities we have today, because we’re not,” he said.
Given the rapid pace of AI advancement, a proactive effort triumphs over a reactive one. To protect consumers, workers, and the economy more broadly, it is imperative that the FTC and DOJ adapt their enforcement strategies to meet the complexities of the AI era.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
The increasing frequency of extreme weather events, which caused over $200 billion in global economic losses in 2023, is disrupting global supply chains and exacerbating migration pressures, particularly for the U.S. Investing in climate resilience abroad offers a significant opportunity for U.S. businesses in technology, engineering, and infrastructure, while also supporting job creation at home.
Early-career and out-of-state teachers tend to be most heavily concentrated in Alaska’s rural schools, where they face a steep curve in adjusting to a new way of life while learning the ropes of teaching.